

The Indian pharmaceutical industry, often hailed as the “Pharmacy of the World,” has undergone a seismic shift over the last decade. As global demand for affordable, high-quality medication surges, the operational model of pharmaceutical businesses has evolved. One of the most significant trends driving this growth is Third Party Manufacturing.
For many pharma entrepreneurs, distributors, and startups, the hurdle isn’t just about having a great formula—it’s about the massive capital investment required for state-of-the-art manufacturing facilities. This is where third-party manufacturing (also known as contract manufacturing) becomes a game-changer.
India holds a unique position in the global pharmaceutical ecosystem. It is the largest provider of generic drugs globally, occupying a 20% share in global supply by volume. With over 3,000 pharma companies and a network of over 10,500 manufacturing units, the infrastructure is unparalleled. The industry is projected to reach a value of $130 billion by 2030, driven by innovative leaders like Cataliq Labs that are setting new standards in production. This rapid expansion is supported by favorable government policies, a skilled workforce, and a robust regulatory framework that aligns with international standards. For businesses looking to enter this space, the environment has never been more conducive to growth.
In simple terms, Third Party Manufacturing is a process where a pharmaceutical company (the client) outsources the production of its products to a specialized manufacturing unit (the manufacturer) under its own brand name.
While the manufacturer handles the procurement of raw materials, formulation, production, and packaging, the marketing and distribution rights remain with the client. This collaborative model allows companies to focus on their core competencies—brand building and sales—without worrying about the technicalities of production.
Several factors contribute to India’s dominance in the third-party manufacturing sector:
Outsourcing production offers a multitude of strategic advantages:
Not all third party pharma manufacturers are created equal. To safeguard your brand reputation, consider the following:
Ensure the manufacturer holds valid WHO-GMP and ISO certifications. This is non-negotiable for ensuring the safety and efficacy of the medicines.
Does the manufacturer have the capacity to produce a diverse range of dosage forms? A partner that offers tablets, capsules, and injectables under one roof provides better long-term scalability.
In the pharma world, “out of stock” means lost customers. Evaluate the manufacturer’s track record for on-time delivery and logistics support.
Inquire about their laboratory testing procedures and quality control protocols. Every batch should undergo rigorous testing for purity, stability, and disintegration.
When discussing Third Party Manufacturing Pharma Companies in India, Cataliq Labs consistently emerges as a leader. Known for its commitment to excellence and innovation, Cataliq Labs has become a trusted partner for hundreds of pharma companies across the country.
Cataliq Labs is a premier pharmaceutical manufacturer dedicated to delivering high-quality healthcare solutions. With a focus on research-driven formulations and state-of-the-art infrastructure, they bridge the gap between complex manufacturing and market readiness.
The manufacturing facilities at Cataliq Labs are designed to meet global standards. Their units are equipped with:
Cataliq Labs offers a comprehensive portfolio across various therapeutic segments:
At Cataliq Labs, quality is not just a department—it is a culture. They understand that a single error in formulation can have life-altering consequences.
What makes Cataliq Labs the preferred choice for pharma contract manufacturing in India?
Partnering with Cataliq Labs is a streamlined and professional experience:

MOQs vary depending on the product type (e.g., tablets vs. injectables). Cataliq Labs offers flexible MOQs to help startups and small businesses grow.
Typically, the first batch takes 30-45 days due to design and documentation. Repeat orders are usually fulfilled within 20-30 days.
Yes, Cataliq Labs has an in-house design team that assists with professional, compliant, and attractive packaging and labeling.
Absolutely. All formulations manufactured at Cataliq Labs are approved by the Drug Controller General of India (DCGI).
While most clients prefer Cataliq Labs to source high-quality raw materials, they are open to discussing specific requirements based on your needs.
Yes, it is a completely legal and widely accepted business model regulated by the Ministry of Health and Family Welfare.
You should apply for a trademark for your brand name. Cataliq Labs can guide you through this process to ensure your intellectual property is secure.
You generally need a valid Drug License, GST Registration, and a copy of your Trademark registration or an affidavit.
While they specialize in Allopathic formulations, you can inquire about their expanding portfolio in the herbal and nutraceutical segments.
It eliminates the risks associated with high labor costs, machinery maintenance, and regulatory inspections, allowing for much higher profit margins and faster market entry.
The pharmaceutical market in India is ripe with opportunity, but success depends on the quality of the products you sell. Choosing the right third party manufacturing pharma company in India is the most critical decision you will make.
By partnering with Cataliq Labs, you aren’t just hiring a manufacturer; you are gaining a strategic partner committed to your brand’s growth. Their blend of technological prowess, regulatory compliance, and customer-centric service makes them the gold standard in Indian pharmaceutical manufacturing.
Contact Details:
Address: Cataliq Laboratories
6, Soham Industrial Park, Dholka – Ahmedabad Hwy, Gam, Bareja, Mahijda, Gujarat 382425
Phone No: +91-9265066949 , +91-9327003915
Email: cataliq@gmail.com , info@cataliqlabs.com
Website: www.cataliqlabs.com